Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb:20:1-5.
doi: 10.1016/j.jdcr.2021.11.023. Epub 2021 Dec 15.

Alopecia areata after SARS-CoV-2 vaccination

Affiliations
Case Reports

Alopecia areata after SARS-CoV-2 vaccination

Margaret E Scollan et al. JAAD Case Rep. 2022 Feb.
No abstract available

Keywords: AA, alopecia areata; COVID-19; ILTAC, intralesional triamcinolone; SARS-CoV-2 vaccination; alopecia areata; case report; hair loss; mRNA vaccine.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Patient timelines showing dates of initial incidence and progression of hair loss, SARS-CoV-2 vaccine series, and presentation at our institution.

References

    1. Sgubbi P., Savoia F., Calderoni O., Longo R., Stinchi C., Tabanelli M. Alopecia areata in a patient with SARS-Cov-2 infection. Dermatol Ther. 2020;33(6):e14295. doi: 10.1111/dth.14295. - DOI - PubMed
    1. Fivenson D. COVID-19: association with rapidly progressive forms of alopecia areata. Int J Dermatol. 2021;60(1):127. doi: 10.1111/ijd.15317. - DOI - PMC - PubMed
    1. United States Department of Health and Human Services (DHHS) Public Health Service (PHS) Centers for Disease Control (CDC)/Food and Drug Administration (FDA) The Vaccine Adverse Event Reporting System (VAERS) 1990 - 11/05/2021, CDC WONDER online database. http://wonder.cdc.gov/vaers.html
    1. Rossi A., Magri F., Michelini S., et al. Recurrence of alopecia areata after covid-19 vaccination: a report of three cases in Italy. J Cosmet Dermatol. 2021;20(12):3753–3757. doi: 10.1111/jocd.14581. - DOI - PubMed
    1. Essam R., Ehab R., Al-Razzaz R., Khater M.W., Moustafa E.A. Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor? J Cosmet Dermatol. 2021;20(12):3727–3729. doi: 10.1111/jocd.14459. - DOI - PMC - PubMed

Publication types